Absci (ABSI) Tax Provisions (2021 - 2026)

Absci's (ABSI) quarterly Tax Provisions came in at $18000.0 in Q1 2026, up 550.0% year-on-year from $2769.2 in Q1 2025, and up 111.11% quarter-over-quarter from -$162000.0 in Q4 2025.

Absci (ABSI) Tax Provisions (2021 - 2026) Analysis & Trends

Absci has disclosed Tax Provisions across 6 years of filings, most recently posting $18000.0 for Q1 2026.

  • Tax Provisions for Q1 2026 came in at $18000.0, up 550.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $91000.0 (up 68.52% YoY), and the FY2025 annual result was $69000.0, down 1.43% from the prior year.
  • Tax Provisions came in at $18000.0 for Q1 2026 at Absci, up from -$162000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $621000.0 in Q1 2022 to a low of -$500000.0 in Q4 2022.
  • The 5-year median for Tax Provisions is $15000.0 (2024), against an average of -$12750.0.
  • Across the five-year window, Tax Provisions plunged 871.43% in 2025 and surged 550.0% in 2026, its largest moves.
  • Absci's Tax Provisions stood at -$500000.0 in 2022, then soared by 109.6% to $48000.0 in 2023, then tumbled by 56.25% to $21000.0 in 2024, then slumped by 871.43% to -$162000.0 in 2025, then surged by 111.11% to $18000.0 in 2026.
  • The last three Tax Provisions figures came in at $18000.0 (Q1 2026), -$162000.0 (Q4 2025), and $104000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -11.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 216,000.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -859,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 221.50 Mn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Absci 1.13 Bn 1.01 Bn - 18,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 18,000.00
Dec 31, 2025 -162,000.00
Sep 30, 2025 104,000.00
Jun 30, 2025 131,000.00
Mar 31, 2025 -4,000.00
Dec 31, 2024 21,000.00
Sep 30, 2024 37,000.00
Mar 31, 2024 12,000.00
Dec 31, 2023 48,000.00
Sep 30, 2023 34,000.00
Jun 30, 2023 11,000.00
Mar 31, 2023 7,000.00
Dec 31, 2022 -500,000.00
Sep 30, 2022 -312,000.00
Jun 30, 2022 -270,000.00
Mar 31, 2022 621,000.00
Dec 31, 2021 -1.10 Mn
Sep 30, 2021 -1.70 Mn
Jun 30, 2021 -5.60 Mn
Mar 31, 2021 -500,000.00